<DOC>
	<DOCNO>NCT02146079</DOCNO>
	<brief_summary>This trial conduct Asia . The aim trial investigate pharmacokinetics ( exposure trial drug body ) , pharmacodynamics ( effect investigate drug body ) , safety tolerability semaglutide healthy male Japanese Caucasian subject .</brief_summary>
	<brief_title>A Trial Assess Pharmacokinetics , Pharmacodynamics , Safety Tolerability Semaglutide Healthy Male Japanese Caucasian Subjects</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Healthy male Japanese Caucasian subject Age 20 55 year ( inclusive ) time sign informed consent Body weight equal 54.0 kg Body mass index ( BMI ) 20.0 25.0 kg/m^2 ( inclusive ) Glycosylated haemoglobin A1c ( HbA1c ) equal 6.0 % For Japanese subject : parent Japanese For Caucasian subject : parent Caucasian Any clinically significant disease history , opinion investigator , systemic organ disease include : cardiological , pulmonary , gastrointestinal , hepatic , neurologic , renal , genitourinary endocrine , dermatologic hematologic diseases Personal family history medullary thyroid carcinoma multiple endocrine neoplasia syndrome type 2 ( MEN2 ) History chronic pancreatitis idiopathic acute pancreatitis Calcitonin equal 50 ng/L History alcohol abuse within 1 year screening , positive result alcohol breath test , consumption 21 unit alcohol weekly : 1 unit alcohol equal approximately 250 mL beer lager , approximately120 mL ( one glass ) wine Japanese sake , approximately 20 mL spirit Smoking 5 cigarette ( include nicotine substitute product ) equivalent , per day unwilling refrain smoke whenever require trial procedure Use prescription drug within 3 week 5 time halflife , whichever longer , prior Visit 2 ( randomisation ) , nonprescription drug within 1 week prior Visit 2 ( randomisation ) . The use vitamin , mineral nutritional supplement , occasional use paracetamol ( acetaminophen ) acetylsalicylic acid permit</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>